ES2105296T3 - Procedimiento de amplificacion de agentes infecciosos para diagnostico "in vitro" sobre cultivos celulares que contienen mycoplasmas. - Google Patents

Procedimiento de amplificacion de agentes infecciosos para diagnostico "in vitro" sobre cultivos celulares que contienen mycoplasmas.

Info

Publication number
ES2105296T3
ES2105296T3 ES93916020T ES93916020T ES2105296T3 ES 2105296 T3 ES2105296 T3 ES 2105296T3 ES 93916020 T ES93916020 T ES 93916020T ES 93916020 T ES93916020 T ES 93916020T ES 2105296 T3 ES2105296 T3 ES 2105296T3
Authority
ES
Spain
Prior art keywords
vitro
infectious agents
diagnosis
amplification
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93916020T
Other languages
English (en)
Inventor
Gerard Papierok
Gerard Pautrat
Claude Escarguel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INT MICROBIO
Original Assignee
INT MICROBIO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INT MICROBIO filed Critical INT MICROBIO
Application granted granted Critical
Publication of ES2105296T3 publication Critical patent/ES2105296T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PROCESO DE AMPLIFICACION DE LOS AGENTES INFECCIOSOS EN DIAGNOSTICO "IN VITRO" DE ECOSISTEMAS QUE AMPLIFICA LA TECNICA CONVENCIONAL DE CULTIVO CELULAR DE VIRUS (POR EJEMPLO: HSV, RSV) Y DE BACTERIAS (POR EJEMPLO: CHLAMYDIAE, LEGIONELLA, HYTERIA). SEGUN UNA APLICACION PARTICULARMENTE INTERESANTE EN LA BUSQUEDA DE LOS AGENTES INFECCIOSOS, SE INFECTAN DICHOS CULTIVOS CELULARES "IN VITRO" CON MICOPLASMAS QUE PERMITEN INDUCIR UNA RESPUESTA CELULAR POTENCIALIZADA POR LA PRESENCIA DEL O DE LOS MICOPLASMAS UTILIZADOS.
ES93916020T 1992-07-21 1993-07-20 Procedimiento de amplificacion de agentes infecciosos para diagnostico "in vitro" sobre cultivos celulares que contienen mycoplasmas. Expired - Lifetime ES2105296T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9209263A FR2694022B1 (fr) 1992-07-21 1992-07-21 Procédé d'amplification des agents infectieux en diagnostic "in vitro" sur cultures cellulaires.

Publications (1)

Publication Number Publication Date
ES2105296T3 true ES2105296T3 (es) 1997-10-16

Family

ID=9432310

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93916020T Expired - Lifetime ES2105296T3 (es) 1992-07-21 1993-07-20 Procedimiento de amplificacion de agentes infecciosos para diagnostico "in vitro" sobre cultivos celulares que contienen mycoplasmas.

Country Status (5)

Country Link
EP (1) EP0649473B1 (es)
DE (1) DE69311552T2 (es)
ES (1) ES2105296T3 (es)
FR (1) FR2694022B1 (es)
WO (1) WO1994002630A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2761698B1 (fr) * 1997-04-04 1999-05-07 Pasteur Merieux Serums Vacc Methode de titrage d'une composition virale complexe

Also Published As

Publication number Publication date
EP0649473B1 (fr) 1997-06-11
WO1994002630A1 (fr) 1994-02-03
EP0649473A1 (fr) 1995-04-26
FR2694022A1 (fr) 1994-01-28
DE69311552D1 (de) 1997-07-17
FR2694022B1 (fr) 1994-09-30
DE69311552T2 (de) 1998-01-22

Similar Documents

Publication Publication Date Title
PT1526172E (pt) Processo para a replicação de vírus influenza em cultura celular e os vírus influenza que podem ser obtidos pelo processo
DE60115600D1 (de) Virusstämme für die onkolytische behandlung von krebs
ES2078214T3 (es) Deteccion de virus mediante amplificacion e hibridacion.
BR9105737A (pt) Processo para reduzir a contaminacao de um produto de amplificacao,conjunto para uso em um tipo de procedimento de amplificacao e processo para amplificar uma sequencia de amplificacao de uma sequencia-alvo
WO1990005520A3 (en) Tissue culture antiviral processes and compositions
ES2098029T3 (es) Vacunas de hepatitis que contienen monofosforil lipido a 3-o-desacilado.
ATE482267T1 (de) Tierzellen und verfahren für die replikation von influenza viren
AU2684792A (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
ES8307500A1 (es) "metodo para inactivar los virus infecciosos contenidos en una composicion enzimatica hemocoagulante".
ATE179614T1 (de) Herpes simplex virus vp16 impfstoffe
ATE165345T1 (de) Sulfonsaeurederivate zur behandlung von viruserkrankungen
ES2097759T3 (es) Anticuerpos especificos para el dominio de fijacion de cd4 de hiv.
ES2067921T3 (es) Una biomasa y un procedimiento para la produccion de virus/antigeno de virus.
ES2187504T3 (es) Vectores no oncovirales, basados en el vmmp, con encapsidacion defectuosa.
RO79525B (ro) Procedeu de preparare a unui vaccin contra influentei
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
IT1254360B (it) Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
ES2058100T3 (es) Vacuna combinada.
ES2105296T3 (es) Procedimiento de amplificacion de agentes infecciosos para diagnostico "in vitro" sobre cultivos celulares que contienen mycoplasmas.
BR9610932A (pt) Processo para armazenar microorganismos, composição de microorganismos e utilização da mesma
ATE333288T1 (de) Gezielte freisetzung von arzneimitteln zur behandlung von virusinfektionen
JPS5543040A (en) Immunity raising agent
DK135588A (da) Inaktivering af hiv i proteinholdige oploesninger ved hjaelp af phenoler
MX9300071A (es) Liberacion de componentes intracelulares.
ES2055610T3 (es) Vacuna contra hrsv.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 649473

Country of ref document: ES